AU2001252255A1 - Method for obtaining specific t-lymphocytes, and for identifying unknown epitopes - Google Patents

Method for obtaining specific t-lymphocytes, and for identifying unknown epitopes

Info

Publication number
AU2001252255A1
AU2001252255A1 AU2001252255A AU5225501A AU2001252255A1 AU 2001252255 A1 AU2001252255 A1 AU 2001252255A1 AU 2001252255 A AU2001252255 A AU 2001252255A AU 5225501 A AU5225501 A AU 5225501A AU 2001252255 A1 AU2001252255 A1 AU 2001252255A1
Authority
AU
Australia
Prior art keywords
lymphocytes
obtaining specific
identifying unknown
unknown epitopes
epitopes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001252255A
Inventor
Catherine Ibisch
Henri Vie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of AU2001252255A1 publication Critical patent/AU2001252255A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/48—Blood cells, e.g. leukemia or lymphoma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/59—Lectins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001252255A 2000-04-12 2001-04-10 Method for obtaining specific t-lymphocytes, and for identifying unknown epitopes Abandoned AU2001252255A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00401019A EP1146119A1 (en) 2000-04-12 2000-04-12 Method for obtaining specific T-lymphocytes, and for identifying unknown epitopes
EP00401019 2000-04-12
PCT/EP2001/004091 WO2001077302A1 (en) 2000-04-12 2001-04-10 Method for obtaining specific t-lymphocytes, and for identifying unknown epitopes

Publications (1)

Publication Number Publication Date
AU2001252255A1 true AU2001252255A1 (en) 2001-10-23

Family

ID=8173647

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001252255A Abandoned AU2001252255A1 (en) 2000-04-12 2001-04-10 Method for obtaining specific t-lymphocytes, and for identifying unknown epitopes

Country Status (4)

Country Link
US (1) US20020064874A1 (en)
EP (1) EP1146119A1 (en)
AU (1) AU2001252255A1 (en)
WO (1) WO2001077302A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7402432B2 (en) * 2003-12-12 2008-07-22 The Brigham And Women's Hospital, Inc. Process for producing T lymphocytes
US20050249699A1 (en) * 2004-05-05 2005-11-10 Stoff Jesse A Immunodynamic complexes and methods for using and preparing such complexes
CN102123732A (en) 2008-06-20 2011-07-13 杜克大学 Compositions, methods and kits for eliciting an immune response
CN101928695B (en) * 2009-06-22 2013-05-01 鑫品生医科技股份有限公司 Method for producing immune cells and method for inducing immune effector cells
CN102585000B (en) * 2012-02-22 2013-05-29 尉军 Tumor marker CD25 autoantibody and application thereof
CN112481703A (en) * 2020-11-30 2021-03-12 南方医科大学南方医院 Method for rapidly determining positive reaction single peptide from hepatitis B virus peptide library and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000150A1 (en) * 1992-06-25 1994-01-06 City Of Hope Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides
DE19619255A1 (en) * 1995-05-17 1996-11-28 Hartmut Prof Dr Link Human cytomegalovirus peptide(s)
DE19710496A1 (en) * 1997-03-13 1998-09-17 Boehringer Mannheim Gmbh Method for the detection of antigen-specific T cells after enrichment of mononuclear cell populations
AU3246399A (en) * 1998-01-19 1999-08-02 Florian Kern Method for identifying t-cell stimulating protein fragments

Also Published As

Publication number Publication date
EP1146119A1 (en) 2001-10-17
US20020064874A1 (en) 2002-05-30
WO2001077302A1 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
AU2000243170A1 (en) Information providing device, and information providing method
AU2002224831A1 (en) Kit and method for determining multiple analytes
AU2001252973A1 (en) Biosensor and related method
AU2002355200A1 (en) Device, kit and method for generating and transporting wet biological samples
AU2001275716A1 (en) File analysis
AU2002220563A1 (en) Method, device and arrangement for inserting extra information
AU2627201A (en) Methods and reagents for facilitating transcription
EP1346662A4 (en) Mascara selecting method, mascara selecting system, and mascara counseling tool
AU2001281633A1 (en) Detection method
AU2001279850A1 (en) Method and arrangement for studsystem
AU2001267978A1 (en) Method for analyzing words
AU2002221740A1 (en) Method for analyzing proteins
AUPR050700A0 (en) Detection method
AUPQ667800A0 (en) Detection method
AU2001252255A1 (en) Method for obtaining specific t-lymphocytes, and for identifying unknown epitopes
AU5867901A (en) Method for detecting tumors
AU2001277799A1 (en) Probe, probe card and probe manufacturing method
AU2001251200A1 (en) Method for colouring hair
AU2002246912A1 (en) Receptor-binding compounds and methods for identifying them
AU2001237530A1 (en) Method
AU2472501A (en) Methods for protein transfer
AU2002246676A1 (en) Methods for determining organisms
AU2001241636A1 (en) Halotherapy method
AU2002220757A1 (en) Method for obtaining azaerythromycin
AU2001242507A1 (en) Method, diagnostic kit and microarray for determining the rhesus factor